Clinical Trials Logo

Clinical Trial Summary

Use of antenatal corticosteroids therapy has increased since the 2000s. The benefits of such a therapy on premature newborns are scientifically and internationally recognized. Nevertheless, few studies have been conducted to investigate the impact of this antenatal corticosteroid therapy on full-term newborns (> 36 weeks' gestation). The aim of this study is to compare the birth parameters of full-term newborns exposed or not to antenatal corticosteroid therapy.


Clinical Trial Description

All children included in the study were born at the Regional Maternity Hospital of Nancy between January 1, 2014 and December 31, 2020. One hundred and twenty-one of them were exposed during pregnancy to antenatal corticosteroids therapy and constitute the exposed arm, whereas 242 were not and constitute the non-exposed arm. Data were collected retrospectively regarding history of pregnancy, birth parameters and neonatal adaptation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05640596
Study type Observational
Source Central Hospital, Nancy, France
Contact
Status Completed
Phase
Start date January 1, 2014
Completion date November 25, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT02249754 - Nutrition Education Package for Infants and Young Child Feeding and Health in Rural Tanzania N/A
Completed NCT02438774 - Intervention in Minimizing Aflatoxins and Fumonisins Exposure to Children Through Food and Breastfeeding in Tanzania N/A
Recruiting NCT03053687 - Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy N/A
Completed NCT03217045 - Nutrition Protocol and Premature Infants' Growth
Recruiting NCT04294368 - Targeted Fortification of Donor Breast Milk in Preterm Infants N/A
Completed NCT02716935 - Prebiotics and Microbiota Composition and Functionality in Rural Burkinabe Infants N/A
Completed NCT02403739 - Visual Interpretation of Neonatal Growth Charts N/A
Completed NCT02236468 - Creating Homestead Agriculture for Nutrition and Gender Equity (CHANGE) in Burkina Faso N/A
Not yet recruiting NCT01494779 - Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A. Phase 1
Completed NCT05946928 - EMERGENCE AGITATION After Premedication IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY
Recruiting NCT03290235 - Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children Phase 4
Completed NCT02259166 - Enhanced Homestead Food Production Plus+ Program in the Lake Zone, Tanzania N/A
Recruiting NCT06071403 - The Effects of Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants
Completed NCT04633135 - Research on Emissions, Air Quality, Climate and Cooking Technologies in Northern Ghana N/A
Completed NCT00174278 - Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary Phase 3
Recruiting NCT05518188 - Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) Phase 1/Phase 2
Completed NCT03635944 - Nutritional Care and Head Growth in Preterm Infants
Completed NCT00813189 - Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid Phase 3